nodes	percent_of_prediction	percent_of_DWPC	metapath
Flavoxate—PDE8B—forebrain—attention deficit hyperactivity disorder	0.0221	0.0566	CbGeAlD
Flavoxate—PDE4C—forebrain—attention deficit hyperactivity disorder	0.0205	0.0524	CbGeAlD
Flavoxate—PDE7A—nervous system—attention deficit hyperactivity disorder	0.0172	0.0441	CbGeAlD
Flavoxate—PDE7A—central nervous system—attention deficit hyperactivity disorder	0.0166	0.0425	CbGeAlD
Flavoxate—PDE7B—nervous system—attention deficit hyperactivity disorder	0.0151	0.0386	CbGeAlD
Flavoxate—PDE8B—midbrain—attention deficit hyperactivity disorder	0.0146	0.0374	CbGeAlD
Flavoxate—PDE7B—central nervous system—attention deficit hyperactivity disorder	0.0145	0.0371	CbGeAlD
Flavoxate—PDE4C—midbrain—attention deficit hyperactivity disorder	0.0135	0.0346	CbGeAlD
Flavoxate—PDE7A—brain—attention deficit hyperactivity disorder	0.0132	0.0337	CbGeAlD
Flavoxate—PDE8A—midbrain—attention deficit hyperactivity disorder	0.0131	0.0336	CbGeAlD
Flavoxate—PDE8B—nervous system—attention deficit hyperactivity disorder	0.012	0.0307	CbGeAlD
Flavoxate—PDE8B—central nervous system—attention deficit hyperactivity disorder	0.0115	0.0296	CbGeAlD
Flavoxate—PDE7B—brain—attention deficit hyperactivity disorder	0.0115	0.0295	CbGeAlD
Flavoxate—PDE8B—cerebellum—attention deficit hyperactivity disorder	0.0113	0.0289	CbGeAlD
Flavoxate—PDE4C—nervous system—attention deficit hyperactivity disorder	0.0111	0.0284	CbGeAlD
Flavoxate—PDE4C—central nervous system—attention deficit hyperactivity disorder	0.0107	0.0274	CbGeAlD
Flavoxate—PDE8A—cerebellum—attention deficit hyperactivity disorder	0.0102	0.026	CbGeAlD
Flavoxate—PDE4B—forebrain—attention deficit hyperactivity disorder	0.0095	0.0243	CbGeAlD
Flavoxate—CHRM2—forebrain—attention deficit hyperactivity disorder	0.00944	0.0242	CbGeAlD
Flavoxate—PDE4D—cerebellum—attention deficit hyperactivity disorder	0.0092	0.0236	CbGeAlD
Flavoxate—PDE8B—brain—attention deficit hyperactivity disorder	0.00917	0.0235	CbGeAlD
Flavoxate—CHRM1—forebrain—attention deficit hyperactivity disorder	0.00859	0.022	CbGeAlD
Flavoxate—PDE4C—brain—attention deficit hyperactivity disorder	0.00849	0.0217	CbGeAlD
Flavoxate—PDE8A—brain—attention deficit hyperactivity disorder	0.00825	0.0211	CbGeAlD
Flavoxate—PDE4A—cerebellum—attention deficit hyperactivity disorder	0.00814	0.0208	CbGeAlD
Flavoxate—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.00798	0.0204	CbGeAlD
Flavoxate—PDE4D—brain—attention deficit hyperactivity disorder	0.00747	0.0191	CbGeAlD
Flavoxate—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.00726	0.0186	CbGeAlD
Flavoxate—PDE4A—brain—attention deficit hyperactivity disorder	0.00661	0.0169	CbGeAlD
Flavoxate—PDE4B—midbrain—attention deficit hyperactivity disorder	0.00628	0.0161	CbGeAlD
Flavoxate—PDE4B—nervous system—attention deficit hyperactivity disorder	0.00516	0.0132	CbGeAlD
Flavoxate—CHRM2—nervous system—attention deficit hyperactivity disorder	0.00512	0.0131	CbGeAlD
Flavoxate—PDE4B—central nervous system—attention deficit hyperactivity disorder	0.00497	0.0127	CbGeAlD
Flavoxate—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.00493	0.0126	CbGeAlD
Flavoxate—PDE4B—cerebellum—attention deficit hyperactivity disorder	0.00485	0.0124	CbGeAlD
Flavoxate—CHRM1—nervous system—attention deficit hyperactivity disorder	0.00466	0.0119	CbGeAlD
Flavoxate—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.00449	0.0115	CbGeAlD
Flavoxate—PDE4B—brain—attention deficit hyperactivity disorder	0.00394	0.0101	CbGeAlD
Flavoxate—CHRM2—brain—attention deficit hyperactivity disorder	0.00392	0.01	CbGeAlD
Flavoxate—CHRM1—brain—attention deficit hyperactivity disorder	0.00356	0.00913	CbGeAlD
Flavoxate—PDE4C—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000709	0.00116	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000707	0.00116	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000706	0.00116	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000705	0.00116	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000705	0.00116	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000705	0.00116	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000701	0.00115	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000699	0.00115	CbGpPWpGaD
Flavoxate—CHRM2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.000694	0.00114	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000694	0.00114	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000685	0.00112	CbGpPWpGaD
Flavoxate—CHRM2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.000682	0.00112	CbGpPWpGaD
Flavoxate—CHRM2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.000674	0.00111	CbGpPWpGaD
Flavoxate—CHRM1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000674	0.00111	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000672	0.0011	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000671	0.0011	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000668	0.0011	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000668	0.0011	CbGpPWpGaD
Flavoxate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000665	0.00109	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000664	0.00109	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000663	0.00109	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000661	0.00108	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000657	0.00108	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000656	0.00108	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000656	0.00108	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000655	0.00107	CbGpPWpGaD
Flavoxate—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000653	0.00107	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000652	0.00107	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000647	0.00106	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000646	0.00106	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000645	0.00106	CbGpPWpGaD
Flavoxate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000644	0.00106	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000644	0.00106	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000642	0.00105	CbGpPWpGaD
Flavoxate—CHRM1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000641	0.00105	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000639	0.00105	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000636	0.00104	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000636	0.00104	CbGpPWpGaD
Flavoxate—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000634	0.00104	CbGpPWpGaD
Flavoxate—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000633	0.00104	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000628	0.00103	CbGpPWpGaD
Flavoxate—CHRM2—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.000628	0.00103	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000626	0.00103	CbGpPWpGaD
Flavoxate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000625	0.00103	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000625	0.00103	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000625	0.00103	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000622	0.00102	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000621	0.00102	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000621	0.00102	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000618	0.00101	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000613	0.00101	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000613	0.00101	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000611	0.001	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00061	0.001	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00061	0.001	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000608	0.000997	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000605	0.000994	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000602	0.000987	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000601	0.000987	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.0006	0.000985	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000596	0.000979	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000595	0.000977	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000595	0.000977	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000591	0.00097	CbGpPWpGaD
Flavoxate—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00059	0.000968	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000588	0.000965	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000585	0.00096	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000584	0.000958	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000584	0.000958	CbGpPWpGaD
Flavoxate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000583	0.000956	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000578	0.000949	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000578	0.000948	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000577	0.000947	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000575	0.000944	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00057	0.000935	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000568	0.000932	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000568	0.000932	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000565	0.000927	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000562	0.000923	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000561	0.00092	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00056	0.000919	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000559	0.000918	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000552	0.000906	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000551	0.000904	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000551	0.000904	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00055	0.000902	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00055	0.000902	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000548	0.000899	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000544	0.000893	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000544	0.000892	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000543	0.000891	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000543	0.00089	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000541	0.000888	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00054	0.000887	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00054	0.000887	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000536	0.000879	CbGpPWpGaD
Flavoxate—CHRM1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000535	0.000878	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000534	0.000876	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000534	0.000876	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000525	0.000862	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000522	0.000857	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000509	0.000835	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000507	0.000831	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000506	0.00083	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.0005	0.000821	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000499	0.000819	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000498	0.000817	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000497	0.000816	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000494	0.00081	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000478	0.000785	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000473	0.000776	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000467	0.000766	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000463	0.00076	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00046	0.000755	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00046	0.000755	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00046	0.000755	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00045	0.000739	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000444	0.000729	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000441	0.000724	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00044	0.000721	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000435	0.000715	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000435	0.000714	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000434	0.000712	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000434	0.000712	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000426	0.000699	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00042	0.00069	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00042	0.00069	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000419	0.000687	CbGpPWpGaD
Flavoxate—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000413	0.000678	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000413	0.000678	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000413	0.000678	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000413	0.000677	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00041	0.000672	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000409	0.000671	CbGpPWpGaD
Flavoxate—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000408	0.00067	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000408	0.00067	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000405	0.000664	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000404	0.000662	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000403	0.000661	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000401	0.000657	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000395	0.000649	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000392	0.000643	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000385	0.000632	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000385	0.000632	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000384	0.000629	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000382	0.000627	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000381	0.000625	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000381	0.000624	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00038	0.000624	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000379	0.000622	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000366	0.0006	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000361	0.000592	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00036	0.000591	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000355	0.000583	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000355	0.000582	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000354	0.000582	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000354	0.000581	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000352	0.000578	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00035	0.000574	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000348	0.000571	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000341	0.00056	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000335	0.00055	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000335	0.00055	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000334	0.000548	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000331	0.000544	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000325	0.000533	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000323	0.000531	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000322	0.000529	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000319	0.000524	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000315	0.000517	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00031	0.000509	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000309	0.000506	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000306	0.000502	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000302	0.000495	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000301	0.000493	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000295	0.000485	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000294	0.000482	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000292	0.000479	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000281	0.000461	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000278	0.000456	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000278	0.000455	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000274	0.00045	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000272	0.000446	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00027	0.000443	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000267	0.000439	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000267	0.000439	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000266	0.000437	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000264	0.000433	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000248	0.000408	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000248	0.000407	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000245	0.000402	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000244	0.0004	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000244	0.0004	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000243	0.000398	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000242	0.000396	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000241	0.000395	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00024	0.000393	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000238	0.000391	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000238	0.00039	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000237	0.000388	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000237	0.000388	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000234	0.000383	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000234	0.000383	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000233	0.000383	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000232	0.000381	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000231	0.000378	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000229	0.000376	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000226	0.00037	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000223	0.000365	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000219	0.000359	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000218	0.000357	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000217	0.000356	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000216	0.000355	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000216	0.000354	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000215	0.000352	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000215	0.000352	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000212	0.000348	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000212	0.000348	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000209	0.000344	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000206	0.000338	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000202	0.000331	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000198	0.000324	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000195	0.00032	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00019	0.000312	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000164	0.000269	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000162	0.000266	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000152	0.00025	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00015	0.000247	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000143	0.000235	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000142	0.000232	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000138	0.000227	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000137	0.000224	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000133	0.000219	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000132	0.000216	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000132	0.000216	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000129	0.000212	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000127	0.000209	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000127	0.000208	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000125	0.000206	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000125	0.000206	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000124	0.000203	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000117	0.000192	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000115	0.000189	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000115	0.000188	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000109	0.000179	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000101	0.000165	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.18e-05	0.000134	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.07e-05	0.000132	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.33e-05	7.11e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.28e-05	7.02e-05	CbGpPWpGaD
